146 related articles for article (PubMed ID: 10806734)
1. [The clinical evaluation of endometrial carcinoma following irradiation for cervical cancer].
Sheng X; Sun J; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):553-5. PubMed ID: 10806734
[TBL] [Abstract][Full Text] [Related]
2. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
Han SW; He B; Tang QP
Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis.
Hellström AC; Sigurjonson T; Pettersson F
Acta Obstet Gynecol Scand; 2001 Feb; 80(2):152-7. PubMed ID: 11167211
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
8. [Malignancy of the uterine body after radiotherapy for carcinoma of uterine cervix--report of 12 cases].
Yu GR
Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):361-3. PubMed ID: 3004856
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
10. Genital carcinoma after radiotherapy for carcinoma of the cervix. Report of two cases.
Hou XH; Qian HN
Chin Med J (Engl); 1991 Apr; 104(4):350-2. PubMed ID: 1648467
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
13. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
14. [Endometrial carcinoma occurred after irradiation therapy for squamous cell carcinoma of the uterine cervix].
Sato N; Tsunoda H; Oki A; Shigemitsu S; Sasaki J; Nishida M; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):75-8. PubMed ID: 7844459
[No Abstract] [Full Text] [Related]
15. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
16. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma following irradiation for cervical cancer: a case report.
Toongsuwan S; Suvonnakote T; Varthananusara C
J Med Assoc Thai; 1980 Jul; 63(7):421-3. PubMed ID: 7410989
[No Abstract] [Full Text] [Related]
18. The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach.
Park TW; Zivanovic O; Theuerkauf I; Dürkop B; Hernando JJ; Simon M; Büttner R; Kuhn W
Int J Oncol; 2004 Apr; 24(4):829-36. PubMed ID: 15010819
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.
Pertschuk LP; Masood S; Simone J; Feldman JG; Fruchter RG; Axiotis CA; Greene GL
Gynecol Oncol; 1996 Oct; 63(1):28-33. PubMed ID: 8898164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
